Form D · Pharmaceuticals

Vitality Biopharma, Inc.

Los Angeles, CA · CIK 0001438943

Offering snapshot reported Nov 8, 2018 · SEC filing

Reported sold
$36M
Offering amount: $36M
Investors reported
32
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 22, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 8, 2018Initial$36,000,000No comparison32SEC filing
May 18, 2015Initial$1,500,000No comparison6SEC filing
Nov 13, 2014Initial$1,470,000No comparison3SEC filing
Nov 9, 2012Initial$500,000No comparison2SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-325386
Includes (i) 6,000,000 shares of common stock purchased for $1.50 per share and warrants to purchase 6,000,000 shares of common stock for $3.00 per share, and (ii) the Exchange Shares (see item 10).

Source: Form D, filed Nov 8, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Maida Anthony, Iii Director
Dhillon Avtar Director
Robert Brooke Director, Executive
Avtar Dhillon Director
Anthony Maida Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1901 Avenue Of The Stars, 2 Nd Floor
Los Angeles, CA, 90067